Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Cash from Operations (2022 - 2026)

Axsome Therapeutics' Cash from Operations history spans 5 years, with the latest figure at 20700000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 52.28% to 20700000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 70730000.0, a 40.22% increase, with the full-year FY2025 number at 93405000.0, up 27.26% from a year prior.
  • Cash from Operations hit 20700000.0 in Q1 2026 for Axsome Therapeutics, down from 18653000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for AXSM hit a ceiling of 1046000.0 in Q3 2025 and a floor of 55349000.0 in Q2 2023.
  • Historically, Cash from Operations has averaged 29653294.12 across 5 years, with a median of 30110000.0 in 2024.
  • Biggest five-year swings in Cash from Operations: plummeted 818.52% in 2024 and later surged 105.61% in 2025.
  • Tracing AXSM's Cash from Operations over 5 years: stood at 27563000.0 in 2022, then dropped by 10.15% to 30362000.0 in 2023, then grew by 13.7% to 26202000.0 in 2024, then increased by 28.81% to 18653000.0 in 2025, then decreased by 10.97% to 20700000.0 in 2026.
  • Business Quant data shows Cash from Operations for AXSM at 20700000.0 in Q1 2026, 18653000.0 in Q4 2025, and 1046000.0 in Q3 2025.